This half-day intellectual property summit, led by principals from Fish & Richardson’s life sciences practice with support from the Berkeley Center for Law & Technology (BCLT), is designed for executives and in-house counsel in the pharmaceutical, biotechnology and life sciences fields. Join us as we address critical issues at the forefront of these industries.
Space is limited, submit your registration request today.
Thought leaders will discuss the industry’s top challenges and provide insights and ideas your company can use to combat these challenges and avoid legal peril.
Learn about issues that will impact the future landscape of the life sciences industry. Fish & Richardson will apply for CLE credit in most states.
Network with colleagues from your field, and have one-on-one conversations with panelists after their presentations.
Registration & Networking
2014 IP Year in Review: Looking Back to Project Ahead
This session will analyze several major developments in the Federal Circuit last year, including changes to the Court’s composition, the state of section 101 defenses after Myriad, emerging trends in obviousness and enablement law after Bristol-Myers Squibb v. Teva Pharmaceuticals and Promega v. Life Technologies, and potential antitrust liability for filing a Hatch-Waxman case or FDA Citizen Petition after Tyco Healthcare v. Mutual Pharmaceutical.
Craig Countryman, Fish & Richardson
Ahmed Davis, Fish & Richardson
The Impact of Inter Partes Review (IPR) in Hatch-Waxman and Biologics Strategies
This presentation will explore the use of IPR from the standpoint of both generic and branded drug companies, including the interplay with Hatch-Waxman litigation and related timing issues. Speakers will also discuss the utility of this tool in the context of biosimilars development and freedom to operate.
Leslie Robbins, Coherus Biosciences, Inc.
Chad Shear, Fish & Richardson
Dorothy Whelan, Fish & Richardson
Managing and Strategizing through Multinational Patent Disputes
Pharmaceutical litigations have as global a reach as the drugs they concern. This session will address tips and tricks for coordinating litigation in civil law and commonwealth countries. Discussion will cover major differences in law and procedure, ways to maximize differences in jurisdictions (such as timing, the fact finder, and scope and use of discovery), and both the benefits and potential pitfalls of having multiple law firms involved in multinational litigation.
Martina Tyreus Hufnal, Fish & Richardson
Jamison Lynch, Gilead Sciences, Inc.
Jason Markwell, Norton Rose Fulbright Canada LLP
Douglas McCann, Fish & Richardson
Criminal and Regulatory Issues and Trends Facing Drug and Medical Device Industries:
From GMP Violations to Anti-Corruption Enforcement
Panelists will touch on a number of recent criminal and regulatory issues facing drug and medical device companies including global anti-corruption efforts, off-label promotion, and Good Manufacturing Practice (GMP) violations. The speakers will not only review important developments from the past year, but also forecast what to expect in 2015.
Thomas Frongillo, Fish & Richardson
William Mateja, Fish & Richardson
Seth Rodner, Dermarche Labs, Inc.
Speakers and hosts for the 2015 Life Sciences Summit will be published as they are announced. To view full biographies for Fish & Richardson attorneys, please visit www.fr.com.
Conference materials will be published as they become available. You may also view them using the complimentary summit app which will provide convenient access to materials during the event.
Sofitel San Francisco is a Bay Area hotel offering modern luxury, attentive service, and beautifully appointed accommodations in a relaxing hotel oasis on the shores of a tranquil lagoon. Ideally situated in Redwood City between San Francisco and San Jose this elegant accommodation is only ten minutes south of the San Francisco Airport.
Sofitel San Francisco Bay
223 Twin Dolphin Drive
Redwood City, CA 94065
The mission of the Berkeley Center for Law & Technology (BCLT) is to foster the beneficial and ethical advancement of technology by guiding the development of intellectual property law, information privacy law, and related areas of law and public policy as they interact with business, science and technical innovation. For more information, visit www.law.berkeley.edu.
Fish & Richardson is a global patent, intellectual property (IP) litigation, and commercial litigation law firm with more than 400 attorneys and technology specialists across the U.S. and Europe. Fish has been named the #1 patent litigation firm in the U.S. for 11 consecutive years. Fish has been winning cases worth billions in controversy – often by making new law – for the most innovative clients and influential industry leaders since 1878. For more information, visit www.fr.com.